- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,850 | 03.07.24 19:00:02 | -1,870 | -1,46% | 125,850 | 125,950 | 127,690 | 127,720 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 82,700 | 03.07.24 19:00:02 | -2,090 | -2,46% | 80,500 | 85,050 | 84,900 | 84,790 |
